The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Rossari Biotech has approved the incorporation of a wholly owned subsidiary in the Republic of Singapore. This is a strategic overseas expansion move to establish a presence in Singapore, likely to support international business operations, exports, or access ASEAN markets. Other routine matters were also approved at the board meeting. The company has not disclosed the initial capital or specific business purpose of the new entity in this filing.
Neutral to mildly positive for shareholders as overseas subsidiary incorporation signals international growth ambitions, though no financial details or business plans have been shared yet. Near-term stock impact is likely limited as this is a standard corporate action.